Retatrutide - Research Grade

Retatrutide

Informative Description: Retatrutide is a synthetic peptide that acts as a triple hormone receptor agonist (tri-agonist). It is designed to simultaneously target the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors, mimicking the synergistic action of these three critical metabolic incretins.
Peptide Function:
Triple Agonist Signaling: Jointly stimulates the GLP-1, GIP, and Glucagon pathways, achieving a metabolic synergy significantly more potent than single or dual-receptor compounds.
 Energy Expenditure Optimization: Promotes thermogenesis and increases resting calorie expenditure by activating the glucagon receptor, thereby accelerating fatty acid oxidation.
 Glycemic Regulation & Satiety: Delays gastric emptying, enhances glucose-dependent insulin secretion, and transmits powerful satiety signals to the central nervous system.
Primary Uses (Research Applications):
 Advanced Weight Loss Studies: Intensively investigated for its unprecedented capability to induce highly efficient and significant reductions in adipose (fat) tissue mass.
 Metabolic Health Research: Utilized in scientific models aimed at reversing non-alcoholic fatty liver disease (hepatic steatosis) and radically improving insulin sensitivity.
 Appetite & Energy Balance Control: Evaluated in research protocols focused on profound appetite suppression and the regulation of basal energy homeostasis.

IMPORTANT NOTICE
FOR RESEARCH USE ONLY.
NOT FOR HUMAN OR VETERINARY CONSUMPTION.

This product is not intended to diagnose, treat, cure, or prevent any disease.